Table 2.
Baseline COIVD-19 symptoms
| Characteristics | Arm 1: HCQ + SOC |
Arm 2: SOC alone |
Total |
|---|---|---|---|
| Number randomized | 55 | 50 | 105 |
| Number with baseline symptom informationa | 55 | 49 | 104 |
| General symptoms, n (%) | |||
| Fever | 5 (9.1) | 4 (8.2) | 9 (8.7) |
| Tiredness | 5 (9.1) | 3 (6.1) | 8 (7.7) |
| Muscle aches | 4 (7.3) | 5 (10.2) | 9 (8.7) |
| Cardio-respiratory, n (%) | |||
| Coughb | 24 (43.6) | 21 (42.9) | 45 (43.3) |
| Running nose | 11 (20.0) | 4 (8.2) | 15 (14.4) |
| Nasal congestion | 5 (9.1) | 3 (6.1) | 8 (7.7) |
| Sore throat | 3 (5.5) | 2 (4.1) | 5 (4.8) |
| Difficulty in breathing | 1 (1.8) | 0 | 1 (0.9) |
| Fast breathing | 0 | 0 | 0 |
| Chest pain | 7 (12.7) | 5 (10.2) | 12 (11.5) |
| Neurological, n (%) | |||
| Headache | 14 (25.5) | 11 (22.4) | 25 (24.0) |
| Dizziness | 1 (1.8) | 3 (6.1) | 4 (3.8) |
| Loss of smell | 7 (12.7) | 5 (10.2) | 12 (11.5) |
| Loss of taste | 5 (9.1) | 4 (8.2) | 9 (8.7) |
| Gastrointestinal, n (%) | |||
| Poor appetite | 5 (9.1) | 4 (8.2) | 9 (8.7) |
a1 participant (in SOC alone) had missing baseline symptom information. Percentages computed on complete cases
b73% (63% in HCQ group, 86% in SOC group) had dry cough among those reported cough